In the analysis whether diabetic status affected associations between adipose SRA1 expression and other markers of inflammation, we found that in people with T2D, SRA1 expression was associated with TLR3 (r = 0.555, p < 0.0001), TLR4 (r = 0.302, p = 0.044), TLR7 (r = 0.292, p = 0.040), TLR9 (r = 0.398, p = 0.003), NF-κB (r = 0.381, p = 0.005, MyD88 (r = 0.311, p = 0.030), TRAF6 (r = 0.286, p = 0.038), and IRF5 (r = 0.288, p = 0.043) expression (Table 4; Figure 7). Here, SRA1 is linked to type 2 diabetes mellitus.